| Total income and fair value gain/(loss) on financial instruments |
656 |
(539) |
(4,020) |
18,235 |
2,149 |
| Income less expenses before reversal/(impairment losses) and provision |
(4,337) |
(27,713) |
(34,995) |
(13,873) |
(24,880) |
| Reversal of impairment |
-- |
-- |
-- |
-- |
6,126 |
| Impairment losses |
-- |
(2,670) |
-- |
-- |
(5,700) |
| Operating loss after reversal/(impairment losses) and provision |
(4,337) |
(30,383) |
(34,995) |
(13,873) |
(24,454) |
| Finance costs |
(171) |
(80) |
(1,013) |
(1,218) |
(1,706) |
| Loss before taxation |
(4,508) |
(30,463) |
(36,008) |
(15,091) |
(26,160) |
| Income tax credit/(expense) |
26 |
5,414 |
(419) |
2,493 |
1,764 |
| Loss for the year |
(4,482) |
(25,049) |
(36,427) |
(12,598) |
(24,396) |
| Non-controlling interests |
-- |
-- |
-- |
-- |
1 |
| Loss attributable to shareholders of the Company |
(4,482) |
(25,049) |
(36,427) |
(12,598) |
(24,395) |
English Version
